Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Health-Active Responsive Materials: Development, Stability, Safety, and Fate Evaluation in Complex Biological Media

Cel

Pathological tissues, such as chronic wounds, carcinogenic burns, and solid tumors, are characterized by a profoundly remodeled extracellular matrix (ECM) that poses a physical barrier to nanomedicine penetration. These environments are further complicated by hostile microconditions, including oxidative stress, acidic pH, enzymatic dysregulation, and chronic inflammation, all of which hinder healing and reduce therapeutic efficacy. Overcoming the formulation challenges and navigating the physiological and immunological barriers within these diseased microenvironments represents a defining frontier for next-generation nanotherapeutics.
HEALSAFE pioneers the development of dynamic, adaptive materials that emulate the responsiveness and intelligence of living tissues. With a strong translational focus and rigorous preclinical validation, HEALSAFE is intended to enhance workforce training and readiness for the era of personalized, responsive medicine.
Key objectives include: (i) Design and synthesis of a modular library of microenvironment-responsive materials and hybrid systems with tunable physicochemical properties for targeted therapeutic applications; (ii) Development and optimization of encapsulation and controlled release mechanisms tailored to complex biological environments; (iii) Evaluation of biocompatibility, safety, and cellular interactions using advanced in vitro 2D and 3D tissue models; (iv) Preclinical demonstration of therapeutic efficacy, biodistribution, and safety in validated in vivo models of wound healing and other relevant pathological conditions; (v) Promotion of international and transdisciplinary collaboration, inter-sectoral knowledge exchange, and capacity building through targeted dissemination and training initiatives. By integrating novel self-assembled stimuli-responsive biomaterials with precision medicine strategies, HEALSAFE sets the stage for transformative advances in nanotherapeutic design and clinical translation.

Dziedzina nauki (EuroSciVoc)

Słowa kluczowe

Program(-y)

Temat(-y)

System finansowania

HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges

Wyświetl wszystkie projekty finansowane w ramach tego programu finansowania

Zaproszenie do składania wniosków

(odnośnik otworzy się w nowym oknie) HORIZON-MSCA-2025-SE-01

Wyświetl wszystkie projekty finansowane w ramach tego zaproszenia

Koordynator

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Wkład UE netto
€ 360 720,00
Koszt całkowity
Brak danych

Uczestnicy (9)

Partnerzy (1)